u.s.

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheterTexas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…

6 months ago
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheterTexas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…

6 months ago

Kia Telluride Receives J.D. Power 2025 U.S. ALG Residual Value Award

2025 Kia Telluride was recognized as the top midsize SUV with 3-row seating for the fourth year in a rowThe…

6 months ago
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic GalactosemiaApplied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

November 27, 2024 16:10 ET | Source: Applied Therapeutics NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc.…

6 months ago
LT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food marketLT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food market

LT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food market

To invest SAR 185 million over the next 5 years in the Kingdom Eyes revenue in the tune of SAR…

6 months ago
LT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food marketLT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food market

LT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food market

To invest SAR 185 million over the next 5 years in the Kingdom Eyes revenue in the tune of SAR…

6 months ago
LT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food marketLT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food market

LT Foods expands its global footprint to the Kingdom of Saudi Arabia to tap the U.S. $ 2 billion rice and rice-based food market

To invest SAR 185 million over the next 5 years in the Kingdom Eyes revenue in the tune of SAR…

6 months ago
Solidion Technology Partners with Taiwan based Giga Solar to develop U.S. battery marketSolidion Technology Partners with Taiwan based Giga Solar to develop U.S. battery market

Solidion Technology Partners with Taiwan based Giga Solar to develop U.S. battery market

Partnership with Foxconn backed Giga Solar will accelerate U.S. manufacturing and commercialization            DALLAS, Nov. 25, 2024 /PRNewswire/ -- Solidion…

6 months ago
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA (arimoclomol) for Treatment of Niemann-Pick Disease Type CZevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA (arimoclomol) for Treatment of Niemann-Pick Disease Type C

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA (arimoclomol) for Treatment of Niemann-Pick Disease Type C

November 21, 2024 16:51 ET | Source: Zevra Therapeutics MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is…

6 months ago
Xinhua Silk Road: Chinese baijiu brand Wuliangye’s “Harmony Global Tour” enters U.S., Peru to boost exchanges between different civilizationsXinhua Silk Road: Chinese baijiu brand Wuliangye’s “Harmony Global Tour” enters U.S., Peru to boost exchanges between different civilizations

Xinhua Silk Road: Chinese baijiu brand Wuliangye’s “Harmony Global Tour” enters U.S., Peru to boost exchanges between different civilizations

BEIJING, Nov. 19, 2024 /PRNewswire/ -- Wuliangye, a leading Chinese baijiu maker, held a concert in Washington, D.C. and showed…

6 months ago
Show more Posts
Show previous Posts